Skip to main content Accessibility help

Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review

  • S. Andalib (a1), M.R. Emamhadi (a2), S. Yousefzadeh-Chabok (a1), S.K. Shakouri (a3), P.F. Høilund-Carlsen (a4), M.S. Vafaee (a4) (a5) (a6) (a7) (a8) and T.M. Michel (a5) (a6) (a7) (a8)...



Selective serotonin reuptake inhibitors (SSRIs) are the most common antidepressants used to preclude maternal pregnancy depression. There is a growing body of literature assessing the association of prenatal exposure to SSRIs with autism spectrum disorder (ASD). The present systematic review and meta-analysis reviewed the medical literature and pooled the results of the association of prenatal exposure to SSRIs with ASD.


Published investigations in English by June 2016 with keywords of selective serotonin reuptake inhibitors, SSRI, autism spectrum disorder, ASD, pregnancy, childhood, children, neurodevelopment were identified using databases PubMed and PMC, MEDLINE, EMBASE, SCOPUS, and Google Scholar. Cochran's Q statistic-value (Q), degree of freedom (df), and I2 indices (variation in odds ratio [OR] attributable to heterogeneity) were calculated to analyze the risk of heterogeneity of the within- and between-study variability. Pooled odds ratio (OR) and 95% confidence interval (CI) were reported by a Mantel–Haenszel test.


There was a non-significant heterogeneity for the included studies ([Q = 3.61, df = 6, P = 0.730], I2 = 0%). The pooled results showed a significant association between prenatal SSRI exposure and ASD (OR = 1.82, 95% CI = 1.59–2.10, Z = 8.49, P = 0.00).


The evidence from the present study suggests that prenatal exposure to SSRIs is associated with a higher risk of ASD.


Corresponding author

*Corresponding author. Fax: +98 133 332 2444. E-mail (S. Andalib).


Hide All

Both co-authors have contributed equally.



Hide All
[1]Lord, CRisi, SDiLavore, PSShulman, CThurm, APickles, AAutism from 2 to 9 years of age. Arch Gen Psychiatry 2006; 63: 694701.
[2]Carper, RAMoses, PTigue, ZDCourchesne, ECerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage 2002; 16: 10381051.
[3]Palmen, SJPol, H.E.H.Kemner, CSchnack, HGDurston, SLahuis, BE, et al.Increased gray-matter volume in medication-naive high-functioning children with autism spectrum disorder. Psychol Med 2005; 35: 561570.
[4]Stigler, KAMcDonald, BCAnand, ASaykin, AJMcDougle, CJStructural and functional magnetic resonance imaging of autism spectrum disorders. Brain Res 2011; 1380: 146161.
[5]Uddin, LQMenon, VYoung, CBRyali, SChen, TKhouzam, A, et al.Multivariate searchlight classification of structural magnetic resonance imaging in children and adolescents with autism. Biol Psychiatry 2011; 70: 833841.
[6]Brun, CCNicolson, RLeporé, NChou, YYVidal, CNDeVito, TJ, et al.Mapping brain abnormalities in boys with autism. Hum Brain Mapp 2009; 30: 38873900.
[7]Nickl-Jockschat, THabel, UMaria Michel, TManning, JLaird, ARFox, PT, et al.Brain structure anomalies in autism spectrum disorder – a meta-analysis of VBM studies using anatomic likelihood estimation. Hum Brain Mapp 2012; 33: 14701489.
[8]Boddaert, NChabane, NBarthelemy, CBourgeois, MPoline, JBrunelle, F, et al.Bitemporal lobe dysfonction in infantile autism: positron emission tomography study. J Radiol 2002; 83: 18291833.
[9]Nickl-Jockschat, TMichel, TThe role of neurotrophic factors in autism. Mol Psychiatry 2011; 16: 478490.
[10]Nickl-Jockschat, TMichel, TGenetic and brain structure anomalies in autism spectrum disorders. Towards an understanding of the aetiopathogenesis?. Der Nervenarzt 2011; 82: 618627.
[11]Abdallah, MWMichel, TMMatrix metalloproteinases in autism spectrum disorders. J Mol Psychiatry 2013;1:1.
[12]Woods, AGWetie, A.G.N.Sokolowska, IRussell, SRyan, JPMichel, TM, et al.Mass spectrometry as a tool for studying autism spectrum disorder. J Mol Psychiatry 2013;1:1.
[13]Michel, TSheldrick, AFrentzel, THerpertz-Dahlmann, BHerpertz, SHabel, U, et al.Evaluation of diagnostic and therapeutic services in German university hospitals for adults with autism spectrum disorder (ASD). Fortschr Neurol Psychiatr 2010; 78: 402413.
[14]Andrade, SERaebel, MABrown, JLane, KLivingston, JBoudreau, D, et al.Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194e1194e5.
[15]Alwan, SReefhuis, JRasmussen, SAFriedman, JMPatterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol 2011; 51: 264270.
[16]El Marroun, HJaddoe, VWHudziak, JJRoza, SJSteegers, EAHofman, A, et al.Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch Gen Psychiatry 2012; 69: 706714.
[17]Munk-Olsen, TGasse, CLaursen, TPrevalence of antidepressant use and contacts with psychiatrists and psychologists in pregnant and postpartum women. Acta Psychiatr Scand 2012; 125: 318324.
[18]Kieler, HArtama, MEngeland, AEricsson, Ö.Furu, KGissler, M, et al.Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012;344:d8012.
[19]Wu, JDavis-Ajami, MLKeiser, SSykes, LAntidepressant prescription medication use patterns among insured, low income pregnant women. Am J Public Health Res 2013; 1: 7277.
[20]Lattimore, KADonn, SMKaciroti, NKemper, ARNeal, CRVazquez, DMSelective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005; 25: 595604.
[21]Ansorge, MSZhou, MLira, AHen, RGingrich, JAEarly-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004; 306: 879881.
[22]Smit-Rigter, LANoorlander, CWvon Oerthel, LChameau, PSmidt, MPvan Hooft, JAPrenatal fluoxetine exposure induces life-long serotonin 5-HT 3 receptor-dependent cortical abnormalities and anxiety-like behaviour. Neuropharmacology 2012; 62: 865870.
[23]Boukhris, TSheehy, OMottron, LBérard, AAntidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr 2016; 170: 117124.
[24]Croen, LAGrether, JKYoshida, CKOdouli, RHendrick, VAntidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011; 68: 11041112.
[25]El Marroun, HWhite, TJvan der Knaap, NJHomberg, JRFernández, GSchoemaker, NK, et al.Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry 2014; 205: 95102.
[26]Hviid, AMelbye, MPasternak, BUse of selective serotonin reuptake inhibitors during pregnancy and risk of autism. New Engl J Med 2013; 369: 24062415.
[27]Huedo-Medina, TBSánchez-Meca, JMarín-Martínez, FBotella, JAssessing heterogeneity in meta-analysis: Q statistic or I 2 index?. Psychol Methods 2006;11:193.
[28]Gidaya, NBLee, BKBurstyn, IYudell, MMortensen, ELNewschaffer, CJIn utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J Autism Dev Disord 2014; 44: 25582567.
[29]Sorensen, MJGronborg, TKChristensen, JParner, ETVestergaard, MSchendel, D, et al.Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol 2013; 5: 449459.
[30]Cryan, JFMarkou, ALucki, IAssessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002; 23: 238245.
[31]Whitaker-Azmitia, PMBehavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int J Dev Neurosci 2005; 23: 7583.
[32]Gardier, AMalagie, ITrillat, AJacquot, CArtigas, FRole of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 1996; 10: 1627.
[33]Anderson, GMCzarkowski, KRavski, NEpperson, CNPlatelet serotonin in newborns and infants: ontogeny, heritability, and effect of in utero exposure to selective serotonin reuptake inhibitors. Pediatr Res 2004; 56: 418422.
[34]Cook, EHLeventhal, BLFreedman, DXFree serotonin in plasma: autistic children and their first-degree relatives. Biol Psychiatry 1988; 24: 488491.
[35]Lam, KSAman, MGArnold, LENeurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27: 254289.
[36]Borue, XChen, JCondron, BGDevelopmental effects of SSRIs: lessons learned from animal studies. Int J Dev Neurosci 2007; 25: 341347.
[37]Harrington, RALee, LCCrum, RMZimmerman, AWHertz-Picciotto, ISerotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy. Autism Res 2013; 6: 149168.
[38]Vorhees, CVAcuff-Smith, KDSchilling, MAFisher, JEMoran, MSBuelke-Sam, JA developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Toxicol Sci 1994; 23: 194205.
[39]Maciag, DSimpson, KLCoppinger, DLu, YWang, YLin, RC, et al.Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology 2006; 31: 4757.
[40]Jones, WKlin, AHeterogeneity and homogeneity across the autism spectrum: the role of development. J Am Acad Child Adolesc Psychiatry 2009; 48: 471473.
[41]Rai, DLee, BKDalman, CGolding, JLewis, GMagnusson, C Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study; 2013.
[42]Harrington, RALee, L.-C.Crum, RMZimmerman, AWHertz-Picciotto, IPrenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 2014;133:e1241e1248.
[43]Brown, HKRay, JGWilton, ASLunsky, YGomes, TVigod, SNAssociation between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children. JAMA 2017; 317: 15441552.
[44]Daniels, JLForssen, UHultman, CMCnattingius, SSavitz, DAFeychting, M, et al.Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics 2008;121:e1357e1362.
[45]Jose, AGupta, SGulati, SSapra, SPrevalence of depression in mothers of children having ASD. Curr Med Res Pract 2017; 7: 1115.


Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review

  • S. Andalib (a1), M.R. Emamhadi (a2), S. Yousefzadeh-Chabok (a1), S.K. Shakouri (a3), P.F. Høilund-Carlsen (a4), M.S. Vafaee (a4) (a5) (a6) (a7) (a8) and T.M. Michel (a5) (a6) (a7) (a8)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review

  • S. Andalib (a1), M.R. Emamhadi (a2), S. Yousefzadeh-Chabok (a1), S.K. Shakouri (a3), P.F. Høilund-Carlsen (a4), M.S. Vafaee (a4) (a5) (a6) (a7) (a8) and T.M. Michel (a5) (a6) (a7) (a8)...
Submit a response


No Comments have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *